Uterine Arterial Embolization With Tris-acryl Gelatin Microspheres
article
OA: closed
CC0
⤵ 6 in-corpus citations
Abstract
Uterine artery embolization (UAE) as an alternative to surgery for the treatment of uterine fibroids and adenomyosis uteri became increasingly popular. While the clinical success of this new treatment strategy is without doubt, there is still considerable uncertainty with respect to the morphologic changes induced by UAE. In this study, a total of 173 women were treated with UAE using tris-acryl gelatin microspheres (TGMS), a new particulate spherical embolic agent, for either symptomatic adenomyosis or leiomyoma. Surgical specimens of 8 women who underwent subsequent myomectomy or hysterectomy were evaluated by conventional histology and immunohistochemistry. TGMS were readily apparent in both macroscopy and routine histology. In patients with fibroids, TGMS accumulated in medium-sized vessels in the direct tumor vicinity, a minor fraction of particles was detected in the outer half of the myometrium and within leiomyomata. In patients with adenomyosis, a random distribution of TGMS was noted throughout the outer half of the myometrium. Freshly infused particles occluded the respective arteries without a significant tissue reaction. In the course of time, a granulomatous foreign body reaction in the vicinity of particles occurred, eventually followed by complete vessel destruction. Leiomyoma treated with UAE showed either hyaline necrosis, coagulative necrosis, or no change at all. Foci of adenomyosis remained unaltered. In conclusion, after UAE with TGMS, particles were identified predominately but not exclusively at the periphery of fibroids. Pathologists must be aware of the morphologic changes induced by UAE in leiomyoma to avoid misinterpretation of induced tissue alterations as signs of malignant tumor growth.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Extracts from "Clinical Evidence": Endometriosis via openalex
- Uterine Artery Embolization for the Treatment of Adenomyosis via openalex
- W1971812204 via openalex
- W1978750421 via openalex
- W1985101146 via openalex
- W1988605646 via openalex
- W1996085529 via openalex
- W2005368439 via openalex
- W2006643262 via openalex
- W2013065616 via openalex
- W2025116192 via openalex
- W2032899304 via openalex
- W2059978870 via openalex
- W2066474711 via openalex
- W2089742114 via openalex
- W2091188079 via openalex
- W2092752354 via openalex
- W2094834752 via openalex
- W2131025532 via openalex
- W2134068782 via openalex
- W2137162879 via openalex
- W2142112794 via openalex
- W2160850561 via openalex
- W2319611721 via openalex
- W2325912285 via openalex
- W4255664903 via openalex
- W4255944605 via openalex
- W6639394763 via openalex
- W6649403449 via openalex
- W6652165348 via openalex
- W1869451324 via openalex
Cited by (6)
- Uterine artery embolization using gelatin sponge particles for symptomatic focal and diffuse adenomyosis 2021
- Long-term efficacy and quality of life associated with laparoscopic bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis 2013
- Uterine Artery Embolization for Symptomatic Adenomyosis: A New Technical Development of the 1-2-3 Protocol and Predictive Factors of MR Imaging Affecting Outcomes 2011
- Uterine Artery Embolization for the Treatment of Adenomyosis 2008
- Uterine Artery Embolization for Symptomatic Adenomyosis with or without Uterine Leiomyomas with the Use of Calibrated Tris-acryl Gelatin Microspheres: Midterm Clinical and MR Imaging Follow-up 2007
- Pathological findings of uterine leiomyomas and adenomyosis following uterine artery embolization 2006
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:35.797702+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK